BMO Capital analyst Keith Bachman lowered the firm’s price target on DXC Technology (DXC) to $17 from $26 and keeps a Market Perform rating on the shares after its Q4 results. The company’s restructuring and path to improved growth appears to remain a work in progress, and while the stock’s valuation remains intriguing, the firm is comfortable remaining on the sidelines until there is evidence of improved and sustainable growth, the analyst tells investors in a research note. The FY26 guide of a 4% y/y organic constant currency decline was also modestly disappointing, BMO added.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXC:
- DXC Technology price target lowered to $18 from $27 at RBC Capital
- DXC Technology price target lowered to $15 from $24 at Stifel
- DXC Technology price target lowered to $16 from $22 at Morgan Stanley
- Cautious Outlook for DXC Technology Amid Slower Growth Projections and Economic Pressures
- DXC Technology Reports Mixed Fiscal 2025 Results